Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Thanks for pointing out the R&D pps for ART opiods. Those suckers should have waited till now to get in. $22/ share is reasonable when ART opiods are launched and required by the FDA and Congress. Competitors are far and few. $22/ share did not include the 20 FDA approved products and did not include Elites 9.99% ownership in one of the largest generic co.s in the USofA, NOVELL LABS.